<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141665450263750%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201904018%26RESULT%3d1%26SIGN%3d2mSGCNML5%252b3gfJkyXSoiJ9XaSJk%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904018&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904018&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904018&amp;v=MTk1NjhIOWpNcTQ5RWJJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3JCUFRYTVpiRzQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#48" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#49" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#53" data-title="1.2 方法">1.2 方法</a></li>
                                                <li><a href="#58" data-title="1.3 疗效评定标准">1.3 疗效评定标准</a></li>
                                                <li><a href="#60" data-title="1.4观察指标">1.4观察指标</a></li>
                                                <li><a href="#62" data-title="1.5 统计学方法">1.5 统计学方法</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#65" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#66" data-title="2.1 临床疗效">2.1 临床疗效</a></li>
                                                <li><a href="#69" data-title="2.2 心功能">2.2 心功能</a></li>
                                                <li><a href="#73" data-title="2.3 心肌酶谱">2.3 心肌酶谱</a></li>
                                                <li><a href="#77" data-title="2.4 疾病相关并发症">2.4 疾病相关并发症</a></li>
                                                <li><a href="#79" data-title="2.5 用药安全性">2.5 用药安全性</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#83" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#52" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组患者一般资料比较&lt;/b&gt; (n=47) "><b>表</b>1 <b>两组患者一般资料比较</b> (n=47) </a></li>
                                                <li><a href="#68" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;两组临床疗效比较&lt;/b&gt; (n=47) "><b>表</b>2 <b>两组临床疗效比较</b> (n=47) </a></li>
                                                <li><a href="#71" data-title="表3 两组治疗前后心功能参数比较（&lt;image id=&quot;107&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904018_10700.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s，n=47) ">表3 两组治疗前后心功能参数比较（<image id="107" type="formula" href="images/XXGK201904018_10700.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=47) </a></li>
                                                <li><a href="#75" data-title="表4 两组治疗前后血清AST、LDH及CK-MB水平比较（&lt;image id=&quot;108&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904018_10800.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s，n=47) ">表4 两组治疗前后血清AST、LDH及CK-MB水平比较（<image id="108" type="formula" href="images/XXGK201904018_10800.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=47) </a></li>
                                                <li><a href="#81" data-title="&lt;b&gt;表&lt;/b&gt;5 &lt;b&gt;两组住院期间并发症发生率比较&lt;/b&gt; (n=47) "><b>表</b>5 <b>两组住院期间并发症发生率比较</b> (n=47) </a></li>
                                                <li><a href="#82" data-title="&lt;b&gt;表&lt;/b&gt;6 &lt;b&gt;两组治疗期间不良反应发生率比较&lt;/b&gt; (n=47) "><b>表</b>6 <b>两组治疗期间不良反应发生率比较</b> (n=47) </a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="Toma M, Ezekowitz JA, Bakal JA, et al.The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure:insights from the ASCEND-HF Trial[J].Eur J Heart Fail, 2014, 16 (3) :334-341." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD15011600003232&amp;v=MjYzMjhxWTlGWk9zTURuODdvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRndRYnhzPU5pZmNhcks5SHRETg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        Toma M, Ezekowitz JA, Bakal JA, et al.The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure:insights from the ASCEND-HF Trial[J].Eur J Heart Fail, 2014, 16 (3) :334-341.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title=" 姚玉龙, 许开亮, 叶明荣, 等.肺部超声在指导急性左心衰竭患者呋塞米使用中的价值[J].蚌埠医学院学报, 2016, 41 (2) :161-163." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=BANG201602008&amp;v=MDY5NTN5am5WN3JCSnl6RmFiRzRIOWZNclk5RmJJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                         姚玉龙, 许开亮, 叶明荣, 等.肺部超声在指导急性左心衰竭患者呋塞米使用中的价值[J].蚌埠医学院学报, 2016, 41 (2) :161-163.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title=" 王伟, 边瓯, 马宁, 等.小剂量托伐普坦联合呋塞米治疗急性心力衰竭合并利尿剂抵抗超高龄老年患者临床评价[J].临床军医杂志, 2016, 44 (6) :601-604." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=JYGZ201606014&amp;v=MDIzNzZxQnRHRnJDVVI3cWZadVptRnlqblY3ckJMelRNZExHNEg5Zk1xWTlFWUlRS0RIODR2UjRUNmo1NE8zenE=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                         王伟, 边瓯, 马宁, 等.小剂量托伐普坦联合呋塞米治疗急性心力衰竭合并利尿剂抵抗超高龄老年患者临床评价[J].临床军医杂志, 2016, 44 (6) :601-604.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title=" 朱俊, 张超锋, 王聪霞.呋塞米与螺内酯不同用药比例治疗慢性心力衰竭的疗效及对血钾水平的影响[J].广西医科大学学报, 2017, 34 (11) :1617-1620." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GXYD201711022&amp;v=MDczMzBiTnJvOUhab1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyQklqWFNhckc0SDk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                         朱俊, 张超锋, 王聪霞.呋塞米与螺内酯不同用药比例治疗慢性心力衰竭的疗效及对血钾水平的影响[J].广西医科大学学报, 2017, 34 (11) :1617-1620.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title=" Ocaranza MP, Gabrielli L, Mora L, et al.Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure[J].Am Heart J, 2011, 161 (5) :931-937." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011702184333&amp;v=MDMyMzFpclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUZ3UWJ4cz1OaWZPZmJLN0h0RE5xSTlIWmVNTEQzODZvQk1UNlQ0UFFILw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                         Ocaranza MP, Gabrielli L, Mora L, et al.Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure[J].Am Heart J, 2011, 161 (5) :931-937.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title=" 慈新, 关胜江, 楚立.Rho/Rho激酶信号转导通路与心力衰竭的研究进展[J].广州医学院学报, 2010, 38 (2) :102-104." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GZXI201002043&amp;v=MTM1NTlCSWpmVFo3RzRIOUhNclk5Qlo0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3I=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[6]</b>
                                         慈新, 关胜江, 楚立.Rho/Rho激酶信号转导通路与心力衰竭的研究进展[J].广州医学院学报, 2010, 38 (2) :102-104.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title=" 殷宇刚, 严斌, 吕磊.盐酸法舒地尔对老年冠心病心力衰竭的临床疗效[J].实用医学杂志, 2015, 31 (14) :2376-2378." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SYYZ201514050&amp;v=MTIyMDlqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3JCTmpUU2RMRzRIOVROcTQ5QVpJUUtESDg0dlI0VDY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[7]</b>
                                         殷宇刚, 严斌, 吕磊.盐酸法舒地尔对老年冠心病心力衰竭的临床疗效[J].实用医学杂志, 2015, 31 (14) :2376-2378.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title=" Tjam EY, Heckman GA, Smith S, et al.Predicting heart failure mortality in frail seniors:comparing the NYHA functional classification with the Resident Assessment Instrument (RAI) 2.0.[J].Int J Cardiol, 2012, 155 (1) :75-80." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012300491736&amp;v=MDM2MzI2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGd1FieHM9TmlmT2ZiSzdIdERPckk5RllPSU9DMzgvb0JNVA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                         Tjam EY, Heckman GA, Smith S, et al.Predicting heart failure mortality in frail seniors:comparing the NYHA functional classification with the Resident Assessment Instrument (RAI) 2.0.[J].Int J Cardiol, 2012, 155 (1) :75-80.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" >
                                        <b>[9]</b>
                                     中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.急性心力衰竭诊断和治疗指南[J].中华心血管病杂志, 2010, 38 (3) :195-208.</a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title=" 郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社, 2002:77-85." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CBBD&amp;filename=0007506725819999&amp;v=MTg2NTg3bjN4RTlmYnZuS3JpZlplWnZGeW50VTcvS0pGc2RWVjI3R2JhNEdOYk9xb2RFYmVJR0JSTTh6eFVTbURkOVNI&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                         郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社, 2002:77-85.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title=" Shah RV, McNulty S, O′Connor CM, et al.Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure:an analysis from diuretic optimization strategies in acute heart Fail[J].Am Heart J, 2012, 164 (6) :862-868." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011702183788&amp;v=MDQwMTNpZk9mYks3SHRETnFJOUhaZU1NQzNReG9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGd1FieHM9Tg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                         Shah RV, McNulty S, O′Connor CM, et al.Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure:an analysis from diuretic optimization strategies in acute heart Fail[J].Am Heart J, 2012, 164 (6) :862-868.
                                    </a>
                                </li>
                                <li id="27">


                                    <a id="bibliography_12" title=" 宋菲, 张冬颖, 刘剑.利尿剂在心力衰竭中的治疗进展[J].医学综述, 2015, 21 (8) :1427-1429." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YXZS201508033&amp;v=MTA4NDBGckNVUjdxZlp1Wm1GeWpuVjdyQlBEWFJmYkc0SDlUTXA0OUdaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                         宋菲, 张冬颖, 刘剑.利尿剂在心力衰竭中的治疗进展[J].医学综述, 2015, 21 (8) :1427-1429.
                                    </a>
                                </li>
                                <li id="29">


                                    <a id="bibliography_13" title=" 代铁成, 赵月.不同剂量利尿剂联合应用对心衰患者血钾的影响[J].心血管康复医学杂志, 2010, 19 (6) :636-638." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201006025&amp;v=MjEwMjVSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyQlBUWE1aYkc0SDlITXFZOUhZWVFLREg4NHY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                         代铁成, 赵月.不同剂量利尿剂联合应用对心衰患者血钾的影响[J].心血管康复医学杂志, 2010, 19 (6) :636-638.
                                    </a>
                                </li>
                                <li id="31">


                                    <a id="bibliography_14" title=" 王京, 张阿宁, 王晨霞.大剂量呋塞米联合螺内酯治疗急性左心衰的临床观察[J].西南国防医药, 2016, 26 (12) :1473-1476." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XNGF201612039&amp;v=MjU3NTNZOUdiWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyQlBTUE1hTEc0SDlmTnI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[14]</b>
                                         王京, 张阿宁, 王晨霞.大剂量呋塞米联合螺内酯治疗急性左心衰的临床观察[J].西南国防医药, 2016, 26 (12) :1473-1476.
                                    </a>
                                </li>
                                <li id="33">


                                    <a id="bibliography_15" title=" 刘铭雅, 魏盟.心肌梗死后心力衰竭发生机制及诊治进展[J].内科理论与实践, 2014, 9 (1) :21-25." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=NKLL201401007&amp;v=MzE3OTFtRnlqblY3ckJLeWJIWXJHNEg5WE1ybzlGWTRRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[15]</b>
                                         刘铭雅, 魏盟.心肌梗死后心力衰竭发生机制及诊治进展[J].内科理论与实践, 2014, 9 (1) :21-25.
                                    </a>
                                </li>
                                <li id="35">


                                    <a id="bibliography_16" title=" 李娜, 孔一慧, 李为民.Rho激酶抑制剂与心力衰竭关系的研究进展[J].心血管病学进展, 2009, 30 (4) :673-676." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGB200904043&amp;v=MTcxODI4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyQlBUWE1iTEc0SHRqTXE0OUJaNFFLREg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[16]</b>
                                         李娜, 孔一慧, 李为民.Rho激酶抑制剂与心力衰竭关系的研究进展[J].心血管病学进展, 2009, 30 (4) :673-676.
                                    </a>
                                </li>
                                <li id="37">


                                    <a id="bibliography_17" title=" 王宇朋, 王萍, 李虹伟.老年急性心力衰竭的研究进展[J].中华老年心脑血管病杂志, 2017, 19 (12) :1342-1344." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=LNXG201712032&amp;v=MDU0MTdvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3JCS1NQVGFiRzRIOWJOclk5R1o=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[17]</b>
                                         王宇朋, 王萍, 李虹伟.老年急性心力衰竭的研究进展[J].中华老年心脑血管病杂志, 2017, 19 (12) :1342-1344.
                                    </a>
                                </li>
                                <li id="39">


                                    <a id="bibliography_18" title=" 张晓平, 徐峰.Rho激酶抑制剂对大鼠压力负荷性心力衰竭保护作用的研究[J].临床和实验医学杂志, 2018, 17 (8) :796-799." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SYLC201808004&amp;v=MzE0MTJPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3JCTmpUSGJiRzRIOW5NcDQ5RllJUUtESDg0dlI0VDZqNTQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[18]</b>
                                         张晓平, 徐峰.Rho激酶抑制剂对大鼠压力负荷性心力衰竭保护作用的研究[J].临床和实验医学杂志, 2018, 17 (8) :796-799.
                                    </a>
                                </li>
                                <li id="41">


                                    <a id="bibliography_19" title=" Wang N, Guan P, Zhang JP, et al.Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways[J].J Cell Biochem, 2011, 112 (7) :1920-1929." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways">
                                        <b>[19]</b>
                                         Wang N, Guan P, Zhang JP, et al.Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways[J].J Cell Biochem, 2011, 112 (7) :1920-1929.
                                    </a>
                                </li>
                                <li id="43">


                                    <a id="bibliography_20" title=" 陈华, 吕妍琨, 杜荣品.Rho激酶抑制剂与芪苈强心胶囊对慢性心力衰竭患者细胞因子的影响[J].世界中医药, 2014, 9 (6) :808-809, 812." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SJZA201406043&amp;v=MDE2NjBGckNVUjdxZlp1Wm1GeWpuVjdyQk5pZlJiN0c0SDlYTXFZOUJaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[20]</b>
                                         陈华, 吕妍琨, 杜荣品.Rho激酶抑制剂与芪苈强心胶囊对慢性心力衰竭患者细胞因子的影响[J].世界中医药, 2014, 9 (6) :808-809, 812.
                                    </a>
                                </li>
                                <li id="45">


                                    <a id="bibliography_21" title=" 刘峰, 李哲, 回志.慢性肾功能衰竭合并急性左心衰竭患者心肌酶、肌钙蛋白的临床意义[J].中国医药导刊, 2016, 18 (5) :450-451." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=DKYY201605010&amp;v=MzI2NjVSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyQklTYlNkN0c0SDlmTXFvOUVaSVFLREg4NHY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[21]</b>
                                         刘峰, 李哲, 回志.慢性肾功能衰竭合并急性左心衰竭患者心肌酶、肌钙蛋白的临床意义[J].中国医药导刊, 2016, 18 (5) :450-451.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(04),461-466 DOI:10.3969/j.issn.1008-0074.2019.04.18            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm">Rho<b>激酶抑制剂联合呋塞米及螺内酯对急性左心衰患者心功能及血清</b>AST、LDH、CK-MB<b>水平的影响</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E4%BB%98%E5%AD%9D%E6%B8%85&amp;code=42560805&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">付孝清</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E9%BB%8E%E6%98%8C%E5%AE%8F&amp;code=42560806&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">黎昌宏</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E8%B0%AD%E6%9D%B0&amp;code=42560807&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">谭杰</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E9%87%8D%E5%BA%86%E5%B8%82%E5%BC%80%E5%B7%9E%E5%8C%BA%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E5%BF%83%E8%A1%80%E7%AE%A1%E5%86%85%E7%A7%91&amp;code=1701514&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">重庆市开州区人民医院心血管内科</a>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E9%87%8D%E5%BA%86%E5%B8%82%E5%BC%80%E5%B7%9E%E5%8C%BA%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E6%80%A5%E8%AF%8A%E7%A7%91&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">重庆市开州区人民医院急诊科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:探讨Rho激酶抑制剂 (RKI) 联合呋塞米及螺内酯在急性左心衰 (ALHF) 治疗中的临床应用价值。<b>方法</b>:2016年4月～2018年2月我院收治的94例ALHF患者被随机均分为利尿剂组 (常规治疗基础上接受呋塞米及螺内酯) 和三联治疗组 (在利尿剂组基础上加用RKI—盐酸法舒地尔) , 两组均连续治疗7d。观察比较两组治疗前后LVESV、LVEDV、LVEF、血清谷草转氨酶 (AST) 、乳酸脱氢酶 (LDH) 、肌酸激酶同工酶 (CK-MB) 水平, 临床疗效。<b>结果</b>:三联治疗组治疗总有效率显著高于利尿剂组 (95.75%比82.98%) , <i>P</i>=0.045。与治疗前比较, 治疗后两组LVEF显著升高, LVESV、LVEDV、血清AST、LDH、CK-MB水平均显著降低, <i>P</i>均=0.001;与利尿剂组比较, 三联治疗组治疗后LVEF[ (48.27±5.95) %比 (55.14±6.74) %]升高更显著, LVESV[ (86.29±10.41) ml比 (65.96±9.84) ml]、LVEDV [ (133.71±13.42) ml比 (120.35±11.25) ml]、血清AST[ (81.23±10.44) U/L比 (57.58±8.42) U/L]、LDH[ (184.24±13.51) U/L比 (124.65±12.42) U/L]、CK-MB[ (187.84±13.45) U/L比 (132.54±11.69) U/L]水平降低更显著, <i>P</i>均=0.001。两组不良反应发生率无显著差异, <i>P</i>均&gt;0.05。<b>结论</b>:Rho激酶抑制剂联合呋塞米与螺内酯治疗ALHF效果显著, 可显著改善心功能、减轻心肌损害, 且安全可靠, 值得推广。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E5%8A%9B%E8%A1%B0%E7%AB%AD&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心力衰竭;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Rho%E7%9B%B8%E5%85%B3%E6%BF%80%E9%85%B6%E7%B1%BB&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Rho相关激酶类;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%91%8B%E5%A1%9E%E7%B1%B3&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">呋塞米;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E8%9E%BA%E5%86%85%E9%85%AF&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">螺内酯;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                                            </p>
                                    <p><b>收稿日期：</b>2018-06-29</p>

            </div>
                    <h1>Influence of Rho kinase inhibitor combined furosemide and spironolactone on cardiac function, serum levels of AST, LDH and CK-MB in patients with acute left heart failure</h1>
                    <h2>
                    <span>FU Xiao-qing</span>
                    <span>LI Chang-hong</span>
                    <span>TAN Jie</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, People's Hospital of Kaizhou District, Chongqing</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>:To explore application value of Rho kinase inhibitor (RKI) combined furosemide and spironolactone in patients with acute left heart failure (ALHF) . <b>Methods</b>:A total of 94 ALHF patients were randomly and equally divided into diuretic group (received furosemide and spironolactone based on routine treatment) and triple therapy group (received RKI--fasudil hydrochloride based on diuretic group) , both groups were continuously treated for 7 d. LVESV, LVEDV, LVEF, serum levels of aspartate transaminase (AST) , lactate dehydrogenase (LDH) and creatine kinase isoenzyme MB (CK-MB) before and after treatment, therapeutic effects were observed and compared between two groups. <b>Results</b>:Total effective rate of triple therapy group was significantly higher than that of diuretic group (95.75% vs. 82.98%) , <i>P</i>=0.045. Compared with before treatment, there was significant rise in LVEF, and significant reductions in LVESV, LVEDV, serum levels of AST, LDH and CK-MB in two groups after treatment, <i>P</i>=0.001 all; compared with diuretic group after treatment, there was significant rise in LVEF [ (48.27±5.95) % vs. (55.14±6.74) %], and significant reductions in LVESV [ (86.29±10.41) ml vs. (65.96±9.84) ml], LVEDV [ (133.71±13.42) ml vs. (120.35±11.25) ml], serum levels of AST [ (81.23±10.44) U/L vs. (57.58±8.42) U/L], LDH[ (184.24±13.51) U/Lvs. (124.65±12.42) U/L]and CK-MB[ (187.84±13.45) U/L vs. (132.54±11.69) U/L] in triple therapy group, <i>P</i>=0.001 all. There was no significant difference in adverse reactions during treatment between two groups, <i>P</i>&gt;0.05 both. <b>Conclusion</b>:Rho kinase inhibitor combined furosemide and spironolactone can significantly improve cardiac function and reduce myocardial damage, and it's safe and reliable, which is worth extending.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Heart%20failure&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Heart failure;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Rho-associated%20kinases&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Rho-associated kinases;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Furosemide&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Furosemide;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Spironolactone&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Spironolactone;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                                            </p>
                                    <p><b>Received：</b> 2018-06-29</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="47">急性左心衰 (Acute left heart failure, ALHF) 是临床上常见的以组织灌注不良及受累心室后向静脉急性淤血为特征的心血管疾病, 呼吸困难、频繁咳嗽为最典型的临床症状。由于ALHF起病急, 病情危重, 可对患者生命安全造成严重威胁, 故早期及时接受有效治疗, 对减少不良事件发生、促进患者预后改善至关重要<citation id="89" type="reference"><link href="5" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。早期应用利尿剂是ALHF治疗中的一项重要措施, 呋塞米是一种广泛用于治疗心力衰竭的袢利尿药, 可有效增加水、钠等排泄, 且其有一定血管扩张作用, 有利于增加肾血流量, 改善髓质部血流供应<citation id="94" type="reference"><link href="7" rel="bibliography" /><link href="9" rel="bibliography" /><sup>[<a class="sup">2</a>,<a class="sup">3</a>]</sup></citation>。螺内酯作为高血压辅助治疗及低钾血症预防药物, 与呋塞米联合可有效增强利尿效应, 并降低低钾血症发生风险, 故上述两种利尿剂多联合用于心力衰竭利尿治疗中<citation id="90" type="reference"><link href="11" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>。此外, 随临床对ALHF的深入研究发现, 作为具有信息传导及分子开关功能的信号多肽, Rho激酶在心力衰竭病理生理过程中具有关键性参与作用<citation id="91" type="reference"><link href="13" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>。文献报道, Rho激酶通过多种血管活性物质相互作用, 对平滑肌细胞结构与功能造成破坏, 进而诱发ALHF<citation id="92" type="reference"><link href="15" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>。而Rho激酶抑制剂则能够有效降低心肌组织中Rho激酶mRNA表达, 其在抑制心衰过程中的作用受到越来越多的临床重视<citation id="93" type="reference"><link href="17" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>。本研究选择我院94例ALHF患者, 分组探讨Rho激酶抑制剂联合呋塞米与螺内酯的临床应用价值, 现报道如下。</p>
                </div>
                <h3 id="48" name="48" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="49" name="49">1.1 一般资料</h4>
                <div class="p1">
                    <p id="50">选择2016年4月～2018年2月我院94例ALHF患者, 其中男45例, 女49例, 年龄27～76 (57.48±10.64) 岁;NYHA心功能分级<citation id="95" type="reference"><link href="19" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>:Ⅲ级44例, Ⅳ级50例;合并症:高血压23例, 冠心病60例, 糖尿病29例, 其他12例;人体质量指数 (BMI) 为18.4～25.7 (22.39±1.10) kg/m<sup>2</sup>。按照随机数字表法, 上述94例患者被随机均分为三联治疗组与利尿剂组, 每组47例。两组基线资料 (性别、年龄、心功能分级、合并症、BMI) 均衡可比 (<i>P</i>均&gt;0.05) 。见表1。本研究经我院医学伦理委员会审批同意。</p>
                </div>
                <div class="p1">
                    <p id="51">纳入标准: (1) 符合《急性心力衰竭诊断和治疗指南》中ALHF诊断标准<citation id="96" type="reference"><link href="21" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>; (2) NYHA心功能分级为Ⅲ～Ⅳ级; (3) 患者或家属知情同意本研究。排除标准: (1) 严重肝、肾功能不全; (2) 合并消化性溃疡等严重消化道疾病; (3) 凝血功能障碍或有出血倾向; (4) 妊娠期或哺乳期妇女; (5) 过敏体质或对研究已知药物成分有过敏史。</p>
                </div>
                <div class="area_img" id="52">
                    <p class="img_tit"><b>表</b>1 <b>两组患者一般资料比较</b> (n=47)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="52" border="1"><tr><td><br /></td><td>三联治疗组<br /> (n=47) </td><td>利尿剂组<br /> (n=47) </td><td><i>t</i>/<i>χ</i><sup>2</sup></td><td><i>P</i></td></tr><tr><td><br />男<i>n</i> (%) </td><td>23 (48.94) </td><td>22 (46.81) </td><td>0.043</td><td>0.836</td></tr><tr><td><br />年龄 (岁) </td><td>56.84±10.23</td><td>58.11±11.04</td><td>0.579</td><td>0.564</td></tr><tr><td><br />NYHA心功能分级</td><td></td><td></td><td>0.171</td><td>0.679</td></tr><tr><td><br />  Ⅲ级<i>n</i> (%) </td><td>21 (44.68) </td><td>23 (48.94) </td><td></td><td></td></tr><tr><td><br />  Ⅳ级<i>n</i> (%) </td><td>26 (55.32) </td><td>24 (51.06) </td><td></td><td></td></tr><tr><td><br />高血压<i>n</i> (%) </td><td>11 (23.40) </td><td>12 (25.53) </td><td>0.058</td><td>0.810</td></tr><tr><td><br />冠心病<i>n</i> (%) </td><td>31 (65.96) </td><td>29 (61.70) </td><td>0.184</td><td>0.668</td></tr><tr><td><br />糖尿病<i>n</i> (%) </td><td>14 (29.79) </td><td>15 (31.91) </td><td>0.050</td><td>0.823</td></tr><tr><td><br />其他<i>n</i> (%) </td><td>7 (14.89) </td><td>5 (10.64) </td><td>0.382</td><td>0.537</td></tr><tr><td><br />人体质量指数 (kg/m<sup>2</sup>) </td><td>22.41±1.09</td><td>22.37±1.11</td><td>0.176</td><td>0.861</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="53" name="53">1.2 方法</h4>
                <h4 class="anchor-tag" id="54" name="54">1.2.1 治疗方法:</h4>
                <div class="p1">
                    <p id="55">入院后两组均迅速建立静脉通道及心电图、血压等监测, 并给予洋地黄制剂、血管扩张药、肾上腺皮质激素、多巴胺等常规治疗, 同时积极治疗原发病, 及时纠正低氧血症及水电解质紊乱、酸碱失衡等, 在此基础上: (1) 利尿剂组加用利尿剂治疗:静脉滴注呋塞米注射液 (江苏悦兴药业有限公司, 国药准字H32020064) 40 mg, 后再静脉泵注呋塞米10 mg/h, 持续12 h, 1次/d;口服螺内酯 (吉林恒星科技制药有限公司, 国药准字H22023086) 20 mg/次, 根据病情服用1～2次/d; (2) 三联治疗组在利尿剂组基础上再联合Rho激酶抑制剂治疗:静脉注射盐酸法舒地尔注射液 (长春海悦药业股份有限公司, 国药准字H20143374) 30 mg/次, 与50～100 ml生理盐水或5%葡萄糖注射液 (糖尿病患者禁用) 混合稀释后使用, 静滴时间控制在30 min, 3次/d。两组均连续治疗7 d。</p>
                </div>
                <h4 class="anchor-tag" id="56" name="56">1.2.2 心肌酶谱检测方法:</h4>
                <div class="p1">
                    <p id="57">抽取患者清晨空腹状态下外周静脉血3 ml, 离心 (离心半径15 cm, 转速3000 r/min, 时间10 min) 后取上层血清送检, 以化学发光法检测血清谷草转氨酶 (AST) 、乳酸脱氢酶 (LDH) 、肌酸激酶同工酶 (CK-MB) 水平, 仪器为美国贝克曼库尔特公司AU5800型全自动生化分析仪, 采用配套试剂盒, 具体操作严格按照试剂盒说明书进行。</p>
                </div>
                <h4 class="anchor-tag" id="58" name="58">1.3 疗效评定标准</h4>
                <div class="p1">
                    <p id="59">采用Lee氏心衰计分法对心力衰竭症状进行评估, 并根据积分变化拟定疗效为显效、有效、无效、加重, 总有效率= (显效例数+有效例数) /总例数×100%;治疗后积分减少&gt;75%为显效, 减少50%～75%为有效, 减少&lt;50%为无效, 治疗后积分较治疗前增加为加重<citation id="97" type="reference"><link href="23" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>。</p>
                </div>
                <h4 class="anchor-tag" id="60" name="60">1.4观察指标</h4>
                <div class="p1">
                    <p id="61"> (1) 临床疗效; (2) 心功能指标:于治疗前后以彩色多普勒超声诊断仪行超声心动图检查, 测量对比两组左心室收缩末期容积 (LVESV) 、左心室舒张末期容积 (LVEDV) 、左心室射血分数 (LVEF) ; (3) 心肌酶谱:对比两组治疗前后血清AST、LDH、CK-MB水平; (4) 疾病相关并发症:统计对比两组住院期间心源性休克、多器官功能衰竭等并发症发生率; (5) 用药安全性:统计对比两组用药期间恶心/呕吐、乏力、低血压、高钾血症、头痛等不良反应发生率。</p>
                </div>
                <h4 class="anchor-tag" id="62" name="62">1.5 统计学方法</h4>
                <div class="p1">
                    <p id="63">采用SPSS 18.0软件统计分析, 计量资料以均数±标准差 (<image id="106" type="formula" href="images/XXGK201904018_10600.jpg" display="inline" placement="inline"><alt></alt></image>±s) 表示, 比较采用<i>t</i>检验, 计数资料以百分率表示, 比较采用<i>χ</i><sup>2</sup>检验。<i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="65" name="65" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="66" name="66">2.1 临床疗效</h4>
                <div class="p1">
                    <p id="67">三联治疗组治疗总有效率95.75%, 显著高于利尿剂组的82.98% (<i>P</i>=0.045) , 见表2。</p>
                </div>
                <div class="area_img" id="68">
                    <p class="img_tit"><b>表</b>2 <b>两组临床疗效比较</b> (n=47)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="68" border="1"><tr><td><br />组别</td><td>显效<br /><i>n</i> (%) </td><td>有效<br /><i>n</i> (%) </td><td>无效<br /><i>n</i> (%) </td><td>加重<br /><i>n</i> (%) </td><td>总有效率<br /><i>n</i> (%) </td></tr><tr><td><br />三联治疗组</td><td>23 (48.94) </td><td>22 (46.81) </td><td>2 (4.26) </td><td>0 (0.0) </td><td>45 (95.75) <sup>△</sup></td></tr><tr><td><br />利尿剂组</td><td>18 (38.30) </td><td>21 (44.68) </td><td>5 (10.64) </td><td>3 (6.38) </td><td>39 (82.98) </td></tr><tr><td><br /><i>χ</i><sup>2</sup>/<i>P</i></td><td></td><td></td><td></td><td></td><td>4.029/0.045</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:与利尿剂组比较△<i>P</i>&lt;0.05, △△<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="69" name="69">2.2 心功能</h4>
                <div class="p1">
                    <p id="70">治疗前两组LVESV、LVEDV、LVEF比较均无显著差异 (<i>P</i>均&gt;0.05) 。与治疗前比较, 治疗后两组LVESV、LVEDV均显著下降, LVEF均显著升高 (<i>P</i>均=0.001) ;且三联治疗组LVESV、LVEDV显著低于利尿剂组, LVEF显著高于利尿剂组 (<i>P</i>均=0.001) , 见表3。</p>
                </div>
                <div class="area_img" id="71">
                    <p class="img_tit">表3 两组治疗前后心功能参数比较（<image id="107" type="formula" href="images/XXGK201904018_10700.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=47)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="71" border="1"><tr><td><br />观察指标</td><td>治疗前</td><td>治疗后</td><td><i>t</i></td><td><i>P</i></td></tr><tr><td><br />LVESV (ml) </td><td></td><td></td><td></td><td></td></tr><tr><td><br /> 三联治疗组</td><td>101.27±13.22</td><td>65.96±9.84<sup>**△△</sup></td><td>14.689</td><td>0.001</td></tr><tr><td><br /> 利尿剂组</td><td>102.42±12.74</td><td>86.29±10.41<sup>**</sup></td><td>6.721</td><td>0.001</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>0.429/0.669</td><td>9.730/0.001</td><td></td><td></td></tr><tr><td><br />LVEDV (ml) </td><td></td><td></td><td></td><td></td></tr><tr><td><br /> 三联治疗组</td><td>148.21±15.63</td><td>120.35±11.25<sup>**△△</sup></td><td>9.918</td><td>0.001</td></tr><tr><td><br /> 利尿剂组</td><td>147.49±16.01</td><td>133.71±13.42<sup>**</sup></td><td>4.522</td><td>0.001</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>0.221/0.826</td><td>5.230/0.001</td><td></td><td></td></tr><tr><td><br />LVEF (%) </td><td></td><td></td><td></td><td></td></tr><tr><td><br /> 三联治疗组</td><td>36.69±5.11</td><td>55.14±6.74<sup>**△△</sup></td><td>14.955</td><td>0.001</td></tr><tr><td><br /> 利尿剂组</td><td>37.42±5.43</td><td>48.27±5.95<sup>**</sup></td><td>9.234</td><td>0.001</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>0.671/0.504</td><td>5.239/0.001</td><td></td><td></td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:LVESV:左心室收缩末期容积, LVEDV:左心室舒张末期容积, LVEF:左心室射血分数。与治疗前比较*<i>P</i>&lt;0.05, **<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="73" name="73">2.3 心肌酶谱</h4>
                <div class="p1">
                    <p id="74">治疗前两组血清AST、LDH及CK-MB水平比较无显著差异 (<i>P</i>均&gt;0.05) 。与治疗前比较, 治疗后两组血清AST、LDH及CK-MB均显著下降 (<i>P</i>均=0.001) ;与利尿剂组比较, 三联治疗组治疗后血清AST、LDH及CK-MB水平降低更显著 (<i>P</i>均=0.001) , 见表4。</p>
                </div>
                <div class="area_img" id="75">
                    <p class="img_tit">表4 两组治疗前后血清AST、LDH及CK-MB水平比较（<image id="108" type="formula" href="images/XXGK201904018_10800.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=47)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="75" border="1"><tr><td><br />观察指标</td><td>治疗前</td><td>治疗后</td><td><i>t</i></td><td><i>P</i></td></tr><tr><td><br />AST (U/L) </td><td></td><td></td><td></td><td></td></tr><tr><td><br /> 三联治疗组</td><td>116.27±12.56</td><td>57.58±8.42<sup>**△△</sup></td><td>26.609</td><td>0.001</td></tr><tr><td><br /> 利尿剂组</td><td>118.01±11.73</td><td>81.23±10.44<sup>**</sup></td><td>16.057</td><td>0.001</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>0.694/0.489</td><td>12.089/0.001</td><td></td><td></td></tr><tr><td><br />LDH (U/L) </td><td></td><td></td><td></td><td></td></tr><tr><td><br /> 三联治疗组</td><td>274.53±15.71</td><td>124.65±12.42<sup>**△△</sup></td><td>51.308</td><td>0.001</td></tr><tr><td><br /> 利尿剂组</td><td>272.49±16.22</td><td>184.24±13.51<sup>**</sup></td><td>28.661</td><td>0.001</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>0.619/0.537</td><td>22.261/0.001</td><td></td><td></td></tr><tr><td><br />CK-MB (U/L) </td><td></td><td></td><td></td><td></td></tr><tr><td><br /> 三联治疗组</td><td>331.42±13.56</td><td>132.54±11.69<sup>**△△</sup></td><td>76.156</td><td>0.001</td></tr><tr><td><br /> 利尿剂组</td><td>329.28±14.01</td><td>187.84±13.45<sup>**</sup></td><td>49.928</td><td>0.001</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>0.753/0.454</td><td>21.275/0.001</td><td></td><td></td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:AST:谷草转氨酶, LDH:乳酸脱氢酶, CK-MB:肌酸激酶同工酶。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="77" name="77">2.4 疾病相关并发症</h4>
                <div class="p1">
                    <p id="78">两组住院期间疾病相关并发症发生率比较无显著差异 (<i>P</i>=0.247) , 见表5。</p>
                </div>
                <h4 class="anchor-tag" id="79" name="79">2.5 用药安全性</h4>
                <div class="p1">
                    <p id="80">治疗期间两组恶心/呕吐、乏力、低血压、高钾血症、头痛等不良反应发生率比较无显著差异 (<i>P</i>=1.000) , 见表6。</p>
                </div>
                <div class="area_img" id="81">
                    <p class="img_tit"><b>表</b>5 <b>两组住院期间并发症发生率比较</b> (n=47)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="81" border="1"><tr><td><br />组别</td><td>心源性休克<br /><i>n</i> (%) </td><td>多器官功能衰竭<br /><i>n</i> (%) </td><td>其他<br /><i>n</i> (%) </td><td>总发生率<br /><i>n</i> (%) </td></tr><tr><td><br />三联治疗组</td><td>2 (4.26) </td><td>1 (2.13) </td><td>2 (4.26) </td><td>5 (10.64) </td></tr><tr><td><br />利尿剂组</td><td>3 (6.38) </td><td>2 (4.26) </td><td>4 (8.51) </td><td>9 (19.15) </td></tr><tr><td><br /><i>χ</i><sup>2</sup></td><td></td><td></td><td></td><td>1.343</td></tr><tr><td><br /><i>P</i></td><td></td><td></td><td></td><td>0.247</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <div class="area_img" id="82">
                    <p class="img_tit"><b>表</b>6 <b>两组治疗期间不良反应发生率比较</b> (n=47)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="82" border="1"><tr><td><br />组别</td><td>恶心/呕吐<br /><i>n</i> (%) </td><td>乏力<br /><i>n</i> (%) </td><td>低血压<br /><i>n</i> (%) </td><td>高钾血症<br /><i>n</i> (%) </td><td>头痛<br /><i>n</i> (%) </td><td>其他<br /><i>n</i> (%) </td><td>总发生率<br /><i>n</i> (%) </td></tr><tr><td><br />三联治疗组</td><td>2 (4.26) </td><td>1 (2.13) </td><td>3 (6.38) </td><td>3 (6.38) </td><td>1 (2.13) </td><td>1 (2.13) </td><td>11 (23.40) </td></tr><tr><td><br />利尿剂组</td><td>1 (2.13) </td><td>2 (4.26) </td><td>2 (4.26) </td><td>4 (8.51) </td><td>0 (0.0) </td><td>2 (4.26) </td><td>11 (23.40) </td></tr><tr><td><br /><i>χ</i><sup>2</sup>/<i>P</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td>0.001/1.000</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h3 id="83" name="83" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="84">ALHF是临床常见心血管疾病, 且近年受多种因素影响, 其罹患者逐渐增多, 成为威胁国民身心健康的重要疾病, 引起临床广泛重视。由于心力衰竭可导致患者出现液体潴留, 而水钠潴留则会进一步引起外周水肿及肺淤血症状, 表现为严重呼吸困难、胸闷、乏力、胸腹水等, 进而致使其活动耐量显著降低, 并严重威胁着患者身心健康<citation id="98" type="reference"><link href="25" rel="bibliography" /><link href="27" rel="bibliography" /><sup>[<a class="sup">11</a>,<a class="sup">12</a>]</sup></citation>。因此, 利尿剂在ALHF治疗中占据重要地位。</p>
                </div>
                <div class="p1">
                    <p id="85">呋塞米为强效利尿剂, 对水与电解质有排泄作用, 故可增加水、钠、钾、氯等排泄, 本品主要通过抑制肾小管髓袢厚壁段对钠与氯的主动重吸收, 促使管腔液钠离子、氯离子浓度升高, 降低髓质间液钠离子及氯离子浓度, 进而降低渗透压梯度差, 减弱肾小管浓缩功能, 以达到促进水、钠等排泄增多, 减轻水钠潴留对机体损害的目的。此外, 为增强利尿效果, 临床多予以利尿剂联合方案治疗ALHF。螺内酯属利尿药, 多用于治疗原发性醛固酮增多症及水肿性疾病, 其可作用于远曲小管及集合管, 通过阻断钠离子-钾离子与钠离子-氢离子交换, 增加钠离子、氯离子及水排泄, 且由于本品仅作用于远曲小管与集合管, 对肾小管其他段无作用, 故利尿作用相对较弱。但研究显示, 在呋塞米基础上联合螺内酯有利尿协同作用, 且螺内酯有对抗其他利尿剂排钾的作用, 对预防低钾血症有一定积极意义, 故能够作为ALHF利尿治疗重要手段<citation id="99" type="reference"><link href="29" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>。王京等<citation id="100" type="reference"><link href="31" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>研究指出, 呋塞米联合螺内酯治疗ALHF利尿效果显著, 且呋塞米利尿作用有显著的剂量-效应关系。</p>
                </div>
                <div class="p1">
                    <p id="86">此外, 由于心肌受损与机械负荷过度有关, 在神经内分泌系统激活与多种细胞因子生成的条件刺激下, 心肌组织中多条信号调节途径亦被激活, 成为心力衰竭发生的关键环节<citation id="103" type="reference"><link href="33" rel="bibliography" /><link href="35" rel="bibliography" /><sup>[<a class="sup">15</a>,<a class="sup">16</a>]</sup></citation>。其中Rho激酶通路的参与, 使平滑肌细胞功能与结构在多种血管活性物质相互作用下被破坏, 进而直接参与了心力衰竭等心血管疾病的病理过程。文献报道, 在细胞水平方面, Rho激酶介导血管平滑肌细胞收缩, 促进细胞增殖与迁移, 进而促使炎性细胞移动;在分子水平方面, Rho激酶过度表达可促进氧化应激、炎性反应等各种相关因子释放增加, 并降低内皮型一氧化氮合成酶水平<citation id="101" type="reference"><link href="37" rel="bibliography" /><sup>[<a class="sup">17</a>]</sup></citation>。动物学研究也显示, 心力衰竭大鼠模型心肌组织Rho激酶mRNA表达显著增高, 进一步证实Rho激酶与心力衰竭发生的关系<citation id="102" type="reference"><link href="39" rel="bibliography" /><sup>[<a class="sup">18</a>]</sup></citation>。心力衰竭上述发生机制为其治疗开辟了一条新的途径, 且目前临床已将Rho激酶抑制剂用于ALHF治疗, 并取得初步成效<citation id="104" type="reference"><link href="41" rel="bibliography" /><link href="43" rel="bibliography" /><sup>[<a class="sup">19</a>,<a class="sup">20</a>]</sup></citation>。盐酸法舒地尔为Rho激酶抑制剂, 其可通过抑制钙敏化效应, 扩张血管;抑制炎性细胞浸润, 减少炎性介质产生, 抑制心室重构;增加内皮型一氧化碳合成酶表达, 促进一氧化氮生成, 减少心脏耗氧量, 保护心肌组织等多重作用机制, 进而改善心衰。本研究在呋塞米及螺内酯利尿基础上联合Rho激酶抑制剂 (盐酸法舒地尔) 治疗ALHF, 结果显示, 治疗后三联治疗组临床疗效、心功能指标均显著优于利尿剂组 (<i>P</i>&lt;0.05或&lt;0.01) , 可见上述联合方案可进一步提高ALHF治疗效果, 改善患者心功能。分析原因可能在于, 利尿剂基础上联合Rho激酶抑制剂, 可有效阻断Rho激酶信号通路在ALHF中的作用, 故可延缓疾病进展, 纠正心肌重构, 对改善心衰症状及心功能具有积极作用。此外, 本研究结果还显示, 住院期间三联治疗组心源性休克等并发症发生率低于利尿剂组, 可见Rho激酶抑制剂联合呋塞米及螺内酯治疗亦有利于通过缓解病情而降低相关并发症发生风险, 但两组并发症发生率无显著差异 (<i>P</i>=0.247) , 可能与研究选择样本量少等因素有关, 但具体原因仍需临床作进一步分析探讨。</p>
                </div>
                <div class="p1">
                    <p id="87">AST、LDH及CK-MB等心肌酶谱指标水平能够准确反映心肌缺血性损伤程度及细胞膜通透性, 故其水平检测在ALHF诊断、病情判断及预后评估、治疗效果评价中有着重要作用<citation id="105" type="reference"><link href="45" rel="bibliography" /><sup>[<a class="sup">21</a>]</sup></citation>。本研究中, 治疗后三联治疗组血清AST、LDH及CK-MB水平均显著低于利尿剂组 (<i>P</i>均=0.001) , 提示Rho激酶抑制剂联合呋塞米与螺内酯有利于降低ALHF患者血清心肌酶谱指标水平, 可能与Rho激酶抑制剂有抑制炎性介质释放、保护心肌组织、抑制心室重构的作用有关, 也为上述联合治疗方案在ALHF治疗中的可行性提供客观证据支持。本研究结果显示, 治疗期间两组用药不良反应发生率无显著差异 (<i>P</i>=1.000) , 可见上述联合用药方案亦不会增加药物副作用, 安全可行。</p>
                </div>
                <div class="p1">
                    <p id="88">综上, Rho激酶抑制剂联合呋塞米与螺内酯治疗ALHF效果显著, 可有效改善患者心功能、减轻心肌损害, 且安全性好, 但由于研究选择样本量少, 故该方案对降低心源性休克等相关并发症发生风险尚缺乏有效数据支持。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD15011600003232&amp;v=MDI1MTJieHM9TmlmY2FySzlIdEROcVk5RlpPc01Ebjg3b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUZ3UQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>Toma M, Ezekowitz JA, Bakal JA, et al.The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure:insights from the ASCEND-HF Trial[J].Eur J Heart Fail, 2014, 16 (3) :334-341.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=BANG201602008&amp;v=MjcwNThyQkp5ekZhYkc0SDlmTXJZOUZiSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b> 姚玉龙, 许开亮, 叶明荣, 等.肺部超声在指导急性左心衰竭患者呋塞米使用中的价值[J].蚌埠医学院学报, 2016, 41 (2) :161-163.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=JYGZ201606014&amp;v=Mjg5MDhadVptRnlqblY3ckJMelRNZExHNEg5Zk1xWTlFWUlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b> 王伟, 边瓯, 马宁, 等.小剂量托伐普坦联合呋塞米治疗急性心力衰竭合并利尿剂抵抗超高龄老年患者临床评价[J].临床军医杂志, 2016, 44 (6) :601-604.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GXYD201711022&amp;v=MTYyMTBiTnJvOUhab1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyQklqWFNhckc0SDk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b> 朱俊, 张超锋, 王聪霞.呋塞米与螺内酯不同用药比例治疗慢性心力衰竭的疗效及对血钾水平的影响[J].广西医科大学学报, 2017, 34 (11) :1617-1620.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011702184333&amp;v=MjQwMTdJOUhaZU1MRDM4Nm9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGd1FieHM9TmlmT2ZiSzdIdEROcQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b> Ocaranza MP, Gabrielli L, Mora L, et al.Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure[J].Am Heart J, 2011, 161 (5) :931-937.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GZXI201002043&amp;v=MDA4NzlHRnJDVVI3cWZadVptRnlqblY3ckJJamZUWjdHNEg5SE1yWTlCWjRRS0RIODR2UjRUNmo1NE8zenFxQnQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[6]</b> 慈新, 关胜江, 楚立.Rho/Rho激酶信号转导通路与心力衰竭的研究进展[J].广州医学院学报, 2010, 38 (2) :102-104.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SYYZ201514050&amp;v=Mjk4NzhyQk5qVFNkTEc0SDlUTnE0OUFaSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[7]</b> 殷宇刚, 严斌, 吕磊.盐酸法舒地尔对老年冠心病心力衰竭的临床疗效[J].实用医学杂志, 2015, 31 (14) :2376-2378.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012300491736&amp;v=MDI2MDlCTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGd1FieHM9TmlmT2ZiSzdIdERPckk5RllPSU9DMzgvbw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b> Tjam EY, Heckman GA, Smith S, et al.Predicting heart failure mortality in frail seniors:comparing the NYHA functional classification with the Resident Assessment Instrument (RAI) 2.0.[J].Int J Cardiol, 2012, 155 (1) :75-80.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" >
                                    <b>[9]</b>
                                 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.急性心力衰竭诊断和治疗指南[J].中华心血管病杂志, 2010, 38 (3) :195-208.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CBBD&amp;filename=0007506725819999&amp;v=MDc4NzJWVjI3R2JhNEdOYk9xb2RFYmVJR0JSTTh6eFVTbURkOVNIN24zeEU5ZmJ2bktyaWZaZVp2RnludFU3L0tKRnNk&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b> 郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社, 2002:77-85.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011702183788&amp;v=Mjg0NzdpbmxVcmZJSUZ3UWJ4cz1OaWZPZmJLN0h0RE5xSTlIWmVNTUMzUXhvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0Rg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b> Shah RV, McNulty S, O′Connor CM, et al.Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure:an analysis from diuretic optimization strategies in acute heart Fail[J].Am Heart J, 2012, 164 (6) :862-868.
                            </a>
                        </p>
                        <p id="27">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YXZS201508033&amp;v=Mjc1NzJPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3JCUERYUmZiRzRIOVRNcDQ5R1o0UUtESDg0dlI0VDZqNTQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b> 宋菲, 张冬颖, 刘剑.利尿剂在心力衰竭中的治疗进展[J].医学综述, 2015, 21 (8) :1427-1429.
                            </a>
                        </p>
                        <p id="29">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201006025&amp;v=MDkwMTNZOUhZWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyQlBUWE1aYkc0SDlITXE=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b> 代铁成, 赵月.不同剂量利尿剂联合应用对心衰患者血钾的影响[J].心血管康复医学杂志, 2010, 19 (6) :636-638.
                            </a>
                        </p>
                        <p id="31">
                            <a id="bibliography_14" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XNGF201612039&amp;v=MjA5NzZxQnRHRnJDVVI3cWZadVptRnlqblY3ckJQU1BNYUxHNEg5Zk5yWTlHYllRS0RIODR2UjRUNmo1NE8zenE=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[14]</b> 王京, 张阿宁, 王晨霞.大剂量呋塞米联合螺内酯治疗急性左心衰的临床观察[J].西南国防医药, 2016, 26 (12) :1473-1476.
                            </a>
                        </p>
                        <p id="33">
                            <a id="bibliography_15" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=NKLL201401007&amp;v=MjkyMzlLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyQkt5YkhZckc0SDlYTXJvOUZZNFE=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[15]</b> 刘铭雅, 魏盟.心肌梗死后心力衰竭发生机制及诊治进展[J].内科理论与实践, 2014, 9 (1) :21-25.
                            </a>
                        </p>
                        <p id="35">
                            <a id="bibliography_16" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGB200904043&amp;v=MTgyODNVUjdxZlp1Wm1GeWpuVjdyQlBUWE1iTEc0SHRqTXE0OUJaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckM=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[16]</b> 李娜, 孔一慧, 李为民.Rho激酶抑制剂与心力衰竭关系的研究进展[J].心血管病学进展, 2009, 30 (4) :673-676.
                            </a>
                        </p>
                        <p id="37">
                            <a id="bibliography_17" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=LNXG201712032&amp;v=MTMxNjBESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3JCS1NQVGFiRzRIOWJOclk5R1pvUUs=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[17]</b> 王宇朋, 王萍, 李虹伟.老年急性心力衰竭的研究进展[J].中华老年心脑血管病杂志, 2017, 19 (12) :1342-1344.
                            </a>
                        </p>
                        <p id="39">
                            <a id="bibliography_18" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SYLC201808004&amp;v=MTczMDBESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3JCTmpUSGJiRzRIOW5NcDQ5RllJUUs=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[18]</b> 张晓平, 徐峰.Rho激酶抑制剂对大鼠压力负荷性心力衰竭保护作用的研究[J].临床和实验医学杂志, 2018, 17 (8) :796-799.
                            </a>
                        </p>
                        <p id="41">
                            <a id="bibliography_19" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways">

                                <b>[19]</b> Wang N, Guan P, Zhang JP, et al.Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways[J].J Cell Biochem, 2011, 112 (7) :1920-1929.
                            </a>
                        </p>
                        <p id="43">
                            <a id="bibliography_20" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SJZA201406043&amp;v=MDQ1NjJmUmI3RzRIOVhNcVk5Qlo0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3JCTmk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[20]</b> 陈华, 吕妍琨, 杜荣品.Rho激酶抑制剂与芪苈强心胶囊对慢性心力衰竭患者细胞因子的影响[J].世界中医药, 2014, 9 (6) :808-809, 812.
                            </a>
                        </p>
                        <p id="45">
                            <a id="bibliography_21" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=DKYY201605010&amp;v=MzEwNDY0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3JCSVNiU2Q3RzRIOWZNcW85RVpJUUtESDg0dlI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[21]</b> 刘峰, 李哲, 回志.慢性肾功能衰竭合并急性左心衰竭患者心肌酶、肌钙蛋白的临床意义[J].中国医药导刊, 2016, 18 (5) :450-451.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201904018" />
        <input id="dpi" type="hidden" value="300" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904018&amp;v=MTk1NjhIOWpNcTQ5RWJJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3JCUFRYTVpiRzQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
